Anesthesia & Life Support in Massachusetts

Pramand LLC develops implantable medical devices using proprietary hydrogel technology to address unmet clinical needs across surgical interventions. The company focuses on creating hydrogel-based solutions that improve patient outcomes while reducing therapy costs. Pramand's portfolio includes three primary product lines: a hydrogel implant for minimizing intrauterine adhesions (IUAs) in gynecological procedures, a dural sealant for watertight dural closure following craniotomy in neurosurgery, and a hemostatic sealant patch for controlling moderate surgical bleeding. The company operates through a business model of self-funding preclinical development with financial partners supporting clinical development and commercialization. Pramand's leadership team has successfully launched over ten hydrogel-based medical device companies that have generated over $4 billion in value and exits, collectively serving over 5 million patients worldwide. The company's proprietary hydrogel platform positions it as a specialized developer in the implantable device sector, with particular expertise in surgical sealants and hemostatic applications.

Mevion Medical Systems is a radiation therapy company specializing in compact proton therapy systems for cancer treatment. Founded in 2004 and based in Littleton, Massachusetts, Mevion has raised $528.5 million in funding and maintains international offices in the United Kingdom and Japan. The company's flagship MEVION S250 Series comprises the MEVION S250 Proton Therapy System, MEVION S250i with advanced pencil beam scanning capabilities, and MEVION S250-FIT, designed for integration into existing radiation oncology departments. Mevion's systems are recognized for their compact design, which significantly reduces footprint, complexity, and capital/operating costs compared to conventional proton therapy equipment. The systems deliver 97–98% uptime and have achieved FDA clearance and CE marking. More NCI-Designated Cancer Centers select Mevion than any competing proton therapy vendor, reflecting strong clinical adoption and market leadership in particle therapy.

InnoVoyce develops advanced solid-state laser technologies for the prevention, diagnosis, and treatment of voice disorders and ENT procedures. The company manufactures the VYLO™ 455nm blue light surgical laser system, engineered for precision soft tissue surgery with up to 30 watts of power and multiple operational modes. InnoVoyce also produces FDA-cleared laser fibers (0.3mm, 0.4mm, 0.6mm diameters) and surgical accessories designed to enhance procedural precision and patient outcomes. Founded through collaboration with Harvard Medical and the Voice Health Institute, InnoVoyce addresses the clinical needs of millions with voice pathologies, offering versatile solutions for laryngeal procedures, voice health restoration, and broader ENT applications. The company maintains active participation in major otolaryngology and head-neck surgery conferences, with ongoing research and development in biomaterials and laser fiber innovation.

Belmont Medical Technologies is a medical device manufacturer specializing in fluid warming, fluid management, and patient temperature regulation solutions for critical care environments. The company develops precision-controlled devices designed for hospitals, surgical centers, emergency transport, military combat fields, and EMS settings. Belmont's portfolio addresses hypothermia prevention, intraoperative normothermia maintenance, and therapeutic temperature management. The Belmont® Rapid Infuser RI-2 delivers warmed blood and fluids at rates from 2.5 to 1000 ml/min with automatic air detection; buddy lite® provides portable, battery-powered warming for field and transport use; Allon® and CritiCool® systems maintain perioperative body temperature non-invasively using algorithm-driven heat pumps and disposable patient garments; and the Hyperthermia Pump™ performs intraperitoneal and thoracic hyperthermic lavage with electromagnetic induction heating. All disposables are aluminum-free and feature intuitive touchscreen interfaces. Belmont has earned significant U.S. military contracts for fluid resuscitation and temperature management.